South Africa's Ramaphosa aims to mend US ties with Musk business push - Watch
Image: Reuters
The South African government is not planning to buy Merck’s COVID-19 treatment pill molnupiravir because an evaluation score from an advisory committee indicated it would not be cost-effective, senior health official Nicholas Crisp told Reuters.
The country’s health regulator SAHPRA said on Thursday that it had authorised use of molnupiravir.
Leave a Reply
Be the First to Comment!
You must be logged in to post a comment.
You must be logged in to post a comment.